Component Therapy in Obstetric Hemorrhage

  • Joseph GriggsEmail author


Postpartum hemorrhage (PPH) remains one of the leading causes of maternal mortality worldwide. Epidemiologic studies have shown a worldwide increase in PPH, extending to developed countries including the United States (US). Although the overall prevalence is low, the rate of PPH in the US has increased from 1.5% in 1999 to 4.1% in 2009 [1]. Numerous national and international societies have invested a great deal of effort in designing Patient Blood Management (PBM) guidelines in an effort to reduce the overall mortality rate associated with PPH. To date, there is no definitive consensus between the various societies’ PBM recommendations. This chapter will highlight a case of life-threatening PPH, detailing blood component therapy in the setting of massive obstetric bleeding. The discussion will include antepartum risk factors for PPH, severity of bleeding assessment, massive transfusion protocols (MTP), lab-directed product replacement, and the use of antifibrinolytic agents. This case and its accompanying information are intended to support the development of an institutional protocol to aggressively manage PPH to reduce the likelihood of hemorrhage-related morbidity and mortality.


ABO blood group Fibrinogen Cryoprecipitate Plasma Platelet Tranexamic acid Massive transfusion protocol Thromboelastometry (TEM) 


  1. 1.
    Kumar N. Postpartum hemorrhage; a major killer of woman: review of current scenario. Obstet Gynecol Int J. 2016;4(4):00116.CrossRefGoogle Scholar
  2. 2.
    Fleischer A, Merowitz N. Care bundles for management of obstetrical hemorrhage. Semin Perinatol. 2016;40(2):99–108.CrossRefPubMedGoogle Scholar
  3. 3.
    Kennedy BB, McMurty Baird S. Collaborative strategies for management of obstetric hemorrhage. Crit Care Nurs Clin N Am. 2017;29(3):315–30.CrossRefGoogle Scholar
  4. 4.
    Lalonde A. FIGO guidelines: prevention and treatment of postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012;117(2):108–18.CrossRefPubMedGoogle Scholar
  5. 5.
    Dutton RP, Shih D, Edelman BB, et al. Safety of uncrossmatched type-O red cells for resuscitation from hemorrhagic shock. J Trauma. 2005;59(6):1445–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Zielinski MD, Johnson PM, Jenkins D, et al. Emergency use of prethawed group A plasma in trauma patients. J Trauma Acute Care Surg. 2013;74(1):69–75.CrossRefPubMedGoogle Scholar
  7. 7.
    Shaylor R, Weiniger CF, Austin N, Tzabazis A, Shander A, Goodnough LT, Butwick AJ. National and international guidelines for patient blood management in obstetrics: a qualitative review. Anesth Analg. 2016;124(1):10.1213.Google Scholar
  8. 8.
    Kacmar RM, Mhyre JM, Scavone BM, Fuller AJ, Toledo P. The use of postpartum hemorrhage protocols in United States academic obstetric anesthesia units. Anesth Analg. 2014;119:906–10.CrossRefPubMedGoogle Scholar
  9. 9.
    Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma the PROPPR randomized clinical trial. JAMA. 2015;313(5):471–82.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Stafford I, Dildy GA, et al. Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol. 2008;199:519.el–7.Google Scholar
  11. 11.
    Hancock A, Weeks AD, Lavender DT. Is accurate and reliable blood loss estimation the ‘crucial step’ in early detection of postpartum haemorrhage: an integrative review of the literature. BMC Pregnancy Childbirth. 2015;15:230.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Vandromme M, Griffin R, Kerby J, et al. Identifying risk for massive transfusion in the relatively normotensive patient: utility of the prehospital shock index. J Trauma. 2011;70(2):384–90.CrossRefPubMedGoogle Scholar
  13. 13.
    Clark S. Obstetric hemorrhage. Semin Perinatol. 2016;40(2):109–11.CrossRefPubMedGoogle Scholar
  14. 14.
    Collins P, Abdul-Kadir R, Thachil J, For the Subcommittees on women’s Health Issues in Thrombosis and Haemostasis and on Disseminated Intravascular Coagulation. Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14:205–10.CrossRefPubMedGoogle Scholar
  15. 15.
    Butwick AJ, Goodnough LT. Transfusion and coagulation management in major obstetric hemorrhage. Curr Opin Anaesthesiol. 2015;28(3):275–84.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Thomas D, Wee M, Clyburn P, et al. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia. 2010;65(11):1153–61.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    CRASH-2 Collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomized controlled trial. Lancet. 2011;377:1096–101.CrossRefGoogle Scholar
  18. 18.
    WOMAN: reducing maternal deaths with tranexamic acid. Lancet. 2017;389(10084):2081.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of PathologyUniversity of New MexicoAlbuquerqueUSA

Personalised recommendations